Related Experiment Video

Updated: Jun 13, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

What are the key targeted delivery technologies of siRNA now?

Mouldy Sioud1

  • 1Department of Immunology, Institute for Cancer Research, Radiumhospitalet-Rikshopitalet Universtity Hospital, Oslo, Norway.

Methods in Molecular Biology (Clifton, N.J.)
|April 14, 2010
PubMed

Insights

Targeted delivery of nucleic acid therapies, like small interfering RNAs (siRNAs), to cancer cells remains a challenge. Receptor-targeted delivery offers a promising strategy to improve therapeutic specificity and minimize damage to healthy cells.

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Oncology

Background:

  • Current nucleic acid delivery methods lack specificity, affecting both normal and cancer cells.
  • Conventional cancer therapies (chemo- and radiotherapy) exhibit toxicity and poor tumor specificity.
  • A critical need exists for targeted drug delivery platforms to spare healthy tissues.

Purpose of the Study:

  • To review advancements in the specific delivery of small interfering RNAs (siRNAs).
  • To highlight receptor-targeted delivery as an innovative strategy for cancer therapeutics.
  • To discuss methods for directing therapeutics selectively to tumor cells.

Main Methods:

  • Exploration of receptor-targeted delivery strategies for therapeutics.
  • Incorporation of receptor-binding ligands (peptides, antibodies, aptamers) into delivery systems.
  • Conjugation of ligands directly to small interfering RNA (siRNA).

Main Results:

  • Receptor-targeted delivery enhances localization of therapeutics to cancer cells expressing cognate receptors.
  • Ligand incorporation into gene delivery vesicles improves targeting efficiency.
  • Direct conjugation of ligands to siRNA facilitates selective cellular uptake.

Conclusions:

  • Receptor-targeted delivery represents a significant advancement in achieving tumor-specific nucleic acid therapy.
  • This approach holds potential for developing more effective and less toxic cancer treatments.
  • Further research in this area is crucial for clinical translation.

More Related Videos

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...